These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 11287108)

  • 1. The mPVN mediates blockade of NPY-induced feeding by a Y5 receptor antagonist: a c-FOS analysis.
    Yokosuka M; Dube MG; Kalra PS; Kalra SP
    Peptides; 2001 Mar; 22(3):507-14. PubMed ID: 11287108
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of neuropeptide Y (NPY)-induced feeding and c-Fos response in magnocellular paraventricular nucleus by a NPY receptor antagonist: a site of NPY action.
    Yokosuka M; Kalra PS; Kalra SP
    Endocrinology; 1999 Oct; 140(10):4494-500. PubMed ID: 10499503
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neural substrates for leptin and neuropeptide Y (NPY) interaction: hypothalamic sites associated with inhibition of NPY-induced food intake.
    Yokosuka M; Xu B; Pu S; Kalra PS; Kalra SP
    Physiol Behav; 1998 Jun; 64(3):331-8. PubMed ID: 9748101
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuropeptide Y Y5 receptor promotes cell growth through extracellular signal-regulated kinase signaling and cyclic AMP inhibition in a human breast cancer cell line.
    Sheriff S; Ali M; Yahya A; Haider KH; Balasubramaniam A; Amlal H
    Mol Cancer Res; 2010 Apr; 8(4):604-14. PubMed ID: 20332211
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Involvement of neuropeptide Y Y1 receptors in the regulation of neuroendocrine corticotropin-releasing hormone neuronal activity.
    Dimitrov EL; DeJoseph MR; Brownfield MS; Urban JH
    Endocrinology; 2007 Aug; 148(8):3666-73. PubMed ID: 17463058
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Food intake in free-feeding and energy-deprived lean rats is mediated by the neuropeptide Y5 receptor.
    Criscione L; Rigollier P; Batzl-Hartmann C; Rüeger H; Stricker-Krongrad A; Wyss P; Brunner L; Whitebread S; Yamaguchi Y; Gerald C; Heurich RO; Walker MW; Chiesi M; Schilling W; Hofbauer KG; Levens N
    J Clin Invest; 1998 Dec; 102(12):2136-45. PubMed ID: 9854049
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence of NPY Y5 receptor involvement in food intake elicited by orexin A in sated rats.
    Dube MG; Horvath TL; Kalra PS; Kalra SP
    Peptides; 2000 Oct; 21(10):1557-60. PubMed ID: 11068104
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of food intake by neuropeptide Y Y5 receptor antisense oligodeoxynucleotides.
    Schaffhauser AO; Stricker-Krongrad A; Brunner L; Cumin F; Gerald C; Whitebread S; Criscione L; Hofbauer KG
    Diabetes; 1997 Nov; 46(11):1792-8. PubMed ID: 9356028
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The neuropeptide Y Y1 receptor knockdown modulates activator protein 1-involved feeding behavior in amphetamine-treated rats.
    Hsieh YS; Chen PN; Yu CH; Liao JM; Kuo DY
    Mol Brain; 2013 Nov; 6():46. PubMed ID: 24225225
    [TBL] [Abstract][Full Text] [Related]  

  • 10. c-fos expression in the rat brain following central administration of neuropeptide Y and effects of food consumption.
    Li BH; Xu B; Rowland NE; Kalra SP
    Brain Res; 1994 Dec; 665(2):277-84. PubMed ID: 7895063
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative distribution of neuropeptide Y Y1 and Y5 receptors in the rat brain by using immunohistochemistry.
    Wolak ML; DeJoseph MR; Cator AD; Mokashi AS; Brownfield MS; Urban JH
    J Comp Neurol; 2003 Sep; 464(3):285-311. PubMed ID: 12900925
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The novel neuropeptide Y Y(1) receptor antagonist J-104870: a potent feeding suppressant with oral bioavailability.
    Kanatani A; Kanno T; Ishihara A; Hata M; Sakuraba A; Tanaka T; Tsuchiya Y; Mase T; Fukuroda T; Fukami T; Ihara M
    Biochem Biophys Res Commun; 1999 Dec; 266(1):88-91. PubMed ID: 10581170
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of neuropeptide Y release by neuropeptide Y receptor ligands and calcium channel antagonists in hypothalamic slices.
    King PJ; Widdowson PS; Doods HN; Williams G
    J Neurochem; 1999 Aug; 73(2):641-6. PubMed ID: 10428060
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence that the inhibition of luteinizing hormone secretion exerted by central administration of neuropeptide Y (NPY) in the rat is predominantly mediated by the NPY-Y5 receptor subtype.
    Raposinho PD; Broqua P; Pierroz DD; Hayward A; Dumont Y; Quirion R; Junien JL; Aubert ML
    Endocrinology; 1999 Sep; 140(9):4046-55. PubMed ID: 10465275
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Orexin-A signaling in the paraventricular nucleus modulates spontaneous firing of glucose-sensitive neurons and promotes food intake via the NPY pathway in rats.
    Wang C; Han X; Guo F; Sun X; Luan X; Xu L
    Biochem Biophys Res Commun; 2018 Oct; 505(1):162-167. PubMed ID: 30243725
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuropeptide Y1 and Y5 receptors mediate the effects of neuropeptide Y on the hypothalamic-pituitary-thyroid axis.
    Fekete C; Sarkar S; Rand WM; Harney JW; Emerson CH; Bianco AC; Beck-Sickinger A; Lechan RM
    Endocrinology; 2002 Dec; 143(12):4513-9. PubMed ID: 12446577
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence for involvement of neuropeptide Y receptors in the regulation of food intake: studies with Y1-selective antagonist BIBP3226.
    Kask A; Rägo L; Harro J
    Br J Pharmacol; 1998 Aug; 124(7):1507-15. PubMed ID: 9723965
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuropeptide Y in central control of feeding and interactions with orexin and leptin.
    Niimi M; Sato M; Taminato T
    Endocrine; 2001 Mar; 14(2):269-73. PubMed ID: 11394646
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of the Y1 receptor in the regulation of neuropeptide Y-mediated feeding: comparison of wild-type, Y1 receptor-deficient, and Y5 receptor-deficient mice.
    Kanatani A; Mashiko S; Murai N; Sugimoto N; Ito J; Fukuroda T; Fukami T; Morin N; MacNeil DJ; Van der Ploeg LH; Saga Y; Nishimura S; Ihara M
    Endocrinology; 2000 Mar; 141(3):1011-6. PubMed ID: 10698177
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interaction of the hypothalamic paraventricular nucleus and central nucleus of the amygdala in naloxone blockade of neuropeptide Y-induced feeding revealed by c-fos expression.
    Pomonis JD; Levine AS; Billington CJ
    J Neurosci; 1997 Jul; 17(13):5175-82. PubMed ID: 9185555
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.